GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Machinery, Furniture, Equipment

Aprinoia Therapeutics (Aprinoia Therapeutics) Machinery, Furniture, Equipment : $0.00 Mil (As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Machinery, Furniture, Equipment?

Aprinoia Therapeutics's Machinery, Furniture, Equipment for the quarter that ended in Jun. 2023 was $0.00 Mil.

Aprinoia Therapeutics's quarterly Machinery, Furniture, Equipment increased from Jun. 2022 ($0.00 Mil) to Dec. 2022 ($2.15 Mil) but then declined from Dec. 2022 ($2.15 Mil) to Jun. 2023 ($0.00 Mil).

Aprinoia Therapeutics's annual Machinery, Furniture, Equipment increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.30 Mil) and increased from Dec. 2021 ($0.30 Mil) to Dec. 2022 ($2.15 Mil).


Aprinoia Therapeutics Machinery, Furniture, Equipment Historical Data

The historical data trend for Aprinoia Therapeutics's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Machinery, Furniture, Equipment Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22
Machinery, Furniture, Equipment
0.30 2.15

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23
Machinery, Furniture, Equipment 0.30 - 2.15 -

Aprinoia Therapeutics Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines